ClinicalTrials.govpublic full text
Olaparib in Subjects With Advanced Pancreatic Acinar Cell Carcinoma
pancreatic acinar cell carcinoma, poly-adp ribose polymerase (parp)-1 inhibitor, homologous recombination repair, platinum-sensitive, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 884045
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.